www.fdanews.com/articles/73338-biosynexus-acquired-by-qvt-fund
Biosynexus Acquired by QVT Fund
June 14, 2005
Biosynexus Incorporated, a biotechnology-pharmaceutical company that is commercializing a portfolio of products for the prevention and treatment of infectious diseases, announced that Biosynexus became a wholly owned subsidiary of QVT Fund LP, as of May 26, 2005. Biosynexus also announced that Dr. Irwin Scher has been appointed Chief Executive Officer.
()a href="http://home.businesswire.com/portal/site/biospace/index.jsp?epi-content=GENERIC&newsId=20050614005086&ndmHsc=v2*A1118142000000*B1118782447000*DgroupByDate*J2*N1000122&newsLang=en&beanID=1229976837&viewID=news_view" target="_blank">BioSpace